SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-325215
Filing Date
2021-11-10
Accepted
2021-11-10 06:49:26
Documents
59
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d98246d10q.htm   iXBRL 10-Q 2174658
2 EX-31.1 d98246dex311.htm EX-31.1 11227
3 EX-31.2 d98246dex312.htm EX-31.2 11249
4 EX-32.1 d98246dex321.htm EX-32.1 6354
  Complete submission text file 0001193125-21-325215.txt   5640064

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA nuvl-20210930.xsd EX-101.SCH 34271
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nuvl-20210930_cal.xml EX-101.CAL 25774
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nuvl-20210930_def.xml EX-101.DEF 200435
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nuvl-20210930_lab.xml EX-101.LAB 288237
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nuvl-20210930_pre.xml EX-101.PRE 250019
10 EXTRACTED XBRL INSTANCE DOCUMENT d98246d10q_htm.xml XML 552291
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Filer) CIK: 0001861560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40671 | Film No.: 211394316
SIC: 2834 Pharmaceutical Preparations